|
Characteristic
|
Total (%)
|
Age group
|
p-value
|
Post hoc contrasts
|
|---|
|
< 60 (%)
|
≥ 60 (%)
|
< 60 (%)
|
≥ 60 (%)
|
p-value
|
|---|
|
Study project
| | | | | | | |
|
Fatigue, Pain, and Sleep
|
28.8
|
28.9
|
28.8
|
.170
| | | |
|
Symptom Prevalence
|
34.4
|
38.0
|
31.5
| | | | |
|
Symptom Clusters
|
36.8
|
33.1
|
39.7
| | | | |
|
Gender- Female
|
54.6
|
70.7
|
41.8
|
< .001
| | | |
|
Lives alone
|
26.4
|
24.0
|
28.2
|
.260
| | | |
|
Partnered/married
|
60.9
|
57.3
|
63.7
|
.126
| | | |
|
Education – Post high school
|
61.4
|
68.8
|
55.5
|
.001
| | | |
|
Diagnosis
| | | | | | | |
|
Breast
|
33.6
|
48.3
|
21.8
| |
48.3
|
21.8
|
.0125
|
|
Prostate
|
26.0
|
11.0
|
37.9
|
< .001
|
11.0
|
37.9
|
.0125
|
|
Lung
|
13.2
|
11.4
|
14.5
| | | | |
|
Other
|
27.3
|
29.3
|
25.8
| | | | |
|
Metastases
|
34.9
|
37.3
|
32.9
|
.297
| | | |
|
Treatment
| | | | | | | |
|
None
|
15.5
|
13.3
|
17.3
| | | | |
|
Only radiation
|
43.6
|
33.8
|
51.4
|
< .001
|
33.8
|
51.4
|
.0125
|
|
Only chemotherapy
|
27.4
|
31.2
|
24.3
| | | | |
|
Both
|
13.5
|
21.7
|
7.0
| |
21.7
|
7.0
|
.0125
|
|
ECOG Performance Status
| | | | | | | |
|
Fully active
|
21.4
|
15.8
|
26.0
| |
15.8
|
26.0
|
.0100
|
|
Ambulatory, light work
|
48.9
|
53.1
|
45.5
|
.043
| | | |
|
Ambulatory, mobile > 50%
|
21.6
|
23.5
|
20.1
| | | | |
|
Ambulatory, mobile < 50%
|
7.2
|
6.5
|
7.7
| | | | |
|
Disabled
|
0.9
|
1.2
|
0.6
| | | | |
|
Age (years; mean (standard deviation))
|
61.3 (12.1)
|
50.3 (7.7)
|
70.1 (6.5)
|
< .001
| | | |
- Abbreviation: ECOG, Eastern Cooperative Oncology Group.
